European mutual recognition procedure approves 32 mg dose for Atacand®
blogdigger
AstraZeneca today announced that the European Mutual Recognition Procedure (MRP) for a 32 mg tablet of its important antihypertensive drug Atacand® (candesartan cilexetil) has been completed... click link for more info.
- link to European mutual recognition procedure approves 32 mg dose for Atacand® -
Last update: 01/25/2005